BioSpace News Archive

Jeffrey D. Marrazzo, chief executive officer of Spark Therapeutics, said his company is the only biotech company that has successfully commercialized a gene therapy for a genetic disease in the United States.

The FDA noted some concerns over the drug’s safety profile. Treatment with selinexor is associated with significant toxicity, the agency noted in its materials.

More news has come from China about the two babies born following He Jiankui’s experiment using CRISPR to make the children resistant to HIV while they were still embryos. Now, there is some evidence to suggest that the two infants could develop genetically-enhanced brains.

Roche’s Flatiron Health and the U.S. Food and Drug Administration’s Information Exchange and Data Transformation (INFORMED) Program expanded a two-year-old collaboration agreement.

Together with its Körber partner companies, Werum is working on solutions that help streamline the complex cell and gene therapy workflows and enable delivery at scale of these critical, life-saving and personalized medicines.

There are numerous questions that often come up in job interviews that most people hate. Examples include “What’s your greatest weakness?” and “Where do you see yourself in five years?”

During his two years in office, former Texas Secretary of State Rolando Pablos flexed the muscles of his office to make recruiting biotech and pharma companies a priority.

Lonza announced the internal alignment of its business structure to accelerate growth along the Healthcare Continuum® and strengthen the Microbial Control business.

Medigene AG reported that the European Patent Office intends to grant a European Patent for the patent application EP3303591A1 covering a T cell receptor building block library that is suitable for rapid reconstruction and testing of newly discovered TCR sequences against classical antigens as well as neoantigens.

An updated webcast of the Soligenix Corporate Presentation, given by Dr. Christopher J. Schaber, President and CEO, is available on the Company website. To listen and view the presentation, please visit www.soligenix.com.